What dose constraints do you when treating a patient with bilateral breast cancers with RNI?

Topics: Breast Cancer • Radiation Oncology

What lung constraints in particular do you use for these cases, and what modifications do you have on these constraints when using hypofractionation in 16 fractions?

Related Questions

What percentage of your breast cancer patients do you plan using IMRT vs 3D?

What criteria do you use to determine the utility of DIBH for breast cancer patients?

How would you manage a ER/PR positive, HER2-negative grade 2 T3N0 invasive breast cancer s/p adjuvant chemotherapy who had post-operative complications with reconstruction?

Do you use traditional bony landmarks or contoured nodal volumes when designing breast and supraclavicular treatment fields?

What is your approach to a tumor bed boost in early stage breast cancer patients with micrometastasis?

Would you offer PMRT for a small focus of invasive disease in a background of extensive DCIS?

What radiation would you offer for isolated nodal recurrence in a patient who received APBI for breast cancer about 2 years ago after ALND?

How would you approach a cT4 cN2 (22 cm in size) TNBC that shrank to 9 cm with KN-522 regimen but remains inoperable at the end of treatment?

For path CR after neoadjuvant chemotherapy in breast cancer with sentinel node (2-3 nodes) negative but >4 nodes positive on initial PET, do you boost the nodes not assessed by sentinel node?

What are best practices for oncologists during the national platinum shortage?